Coronary Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
All the vital news, analysis, and commentary curated by our industry experts.
Coronary Stents Market Overview
The coronary stents market size was valued at $5.03 billion in 2023 and is forecast to grow at a CAGR of less than 1% during 2023 and 2033. A coronary stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The coronary stent system consists of a stent and balloon catheter delivery system.
Coronary Stents Market Outlook, 2023-2033 ($ Billion)
Buy The Full Report for More Insights into The Coronary Stents Market Forecast, Download A Free Report Sample
The coronary stents market research report explains the market behavior, which will help identify quantitative market trends within the cardiovascular devices therapeutic area. The model discusses in detail the impact of COVID-19 on the coronary stents market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing in-licensing and out-licensing strategies.
|Market Size (2023)
|North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa
|Coronary Bare Metal Stents (BMS), Coronary Drug Eluting Stents, Coronary Covered Stents, Coronary Bioabsorbable Stents
|Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, B. Braun Melsungen AG, MicroPort Scientific Corp, and Sahajanand Medical Technologies Pvt Ltd
Coronary Stents Market Dynamics
Changing lifestyles and unhealthy diets in most developed countries have increased the risk of coronary heart disease among individuals. There has been a surge in the demand for Percutaneous Coronary Intervention (PCI) and stenting procedures to treat AP and MI. Angina Pectoris (AP) denotes the presence of coronary artery disease (CAD) with an increased risk of myocardial infarction (MI) also known as a heart attack.
Many developing countries still require better healthcare infrastructure and resources before performing rates of PCI procedures comparable to developed nations. However, as healthcare infrastructure improves and more resources are invested, PCI procedures will be recognized as necessary to treat coronary artery disease thereby driving the market growth during the forecast period.
Coronary Stents Market Segments
The Coronary Stents Market is segmented into Coronary Bare Metal Stents (BMS), Coronary Drug Eluting Stents (DES), Coronary Covered Stents, and Coronary Bioabsorbable Stents (BAS). The DES segment accounted for the largest market share in 2023. The volume of DES devices used is increasing globally due to their superior clinical outcomes compared to other stents.
Coronary Stents Market Analysis by Segments, 2023 (%)
Buy The Full Report for More Insights into The Coronary Stents Market Segments, Download A Free Report Sample
Coronary Stents Market Segmentation by Regions
The key regions in the coronary stents market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. North America accounted for the highest share of the coronary stents market in 2023. The North American coronary stents market is mostly driven by DES devices, which are used in more than 95% of PCI cases. The US and Canada will see stable growth in the coronary stent market during the forecast period. Due to a rise in the aging population, the burden of CHD remains high. Additionally, better PCI techniques and tools will allow physicians to treat patients with PCI, thereby increasing the demand for stents.
Coronary Stents Market Analysis by Regions
Buy The Full Report for More Regional Insights into The Coronary Stents Market, Download A Free Report Sample
Coronary Stents Market - Competitive Landscape
A few of the leading companies in the coronary stents market are Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, B. Braun Melsungen AG, MicroPort Scientific Corp, and Sahajanand Medical Technologies Pvt Ltd among others. Boston Scientific Corp held the largest share of the coronary stents market in 2023.
Coronary Stents Market Analysis by Companies, 2023 (%)
Buy The Full Report to Know More About The Leading Companies In the Coronary Stents Market, Download A Free Report Sample
Segments Covered in the Report
Coronary Stents Segments Outlook (Value, $ Billion, 2015-2033)
- Coronary Bare Metal Stents
- Coronary Drug Eluting Stents
- Coronary Covered Stents
- Coronary Bioabsorbable Stents
Coronary Stents Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Asia Pacific
- South Central America
- Middle East and Africa
Currently marketed Coronary Stents market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total Coronary Stents market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices, and market values by segment.
Global, Regional, and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Coronary Stents market.
- Competitive dynamics insights and trends provided Coronary Stents market.
Understand the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends. These include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies Covered: Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Lepu Medical Technology (Beijing) Co Ltd, B. Braun Melsungen AG, MicroPort Scientific Corp, Sahajanand Medical Technologies Pvt Ltd, Meril Life Sciences Pvt Ltd, Translumina GmbH, Vascular Concepts Ltd, and Others.
Countries Covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This market model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –
- CMO executives who must have a deep understanding of the Coronary Stents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on the Coronary Stents market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Coronary Stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Coronary Stents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Coronary Stents market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Biotronik SE & Co KG
Lepu Medical Technology (Beijing) Co Ltd
B. Braun Melsungen AG
MicroPort Scientific Corp
Sahajanand Medical Technologies Pvt Ltd
Meril Life Sciences Pvt Ltd
Translumina Therapeutics LLP
Vascular Concepts Ltd
Frequently asked questions
What was the coronary stents market size in 2023?
The coronary stents market size was valued at $5.03 billion in 2023.
Which region held the highest share of the coronary stents market in 2023?
Europe accounted for the highest share of the coronary stents market in 2023.
Which segment accounted for the largest share of the coronary stents market in 2022?
The coronary drug eluting stents segment accounted for the highest share of the market and will continue to drive growth throughout the forecast period.
Who are the major players operating in the coronary stents market?
A few of the leading companies in the Coronary Stents market are Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, B. Braun Melsungen AG, MicroPort Scientific Corp, and Sahajanand Medical Technologies Pvt Ltd among others.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.